Page 13 - 2023 Westchester County Economic Development Guide
P. 13
Marsha Gordon is Westchester’s own force for good. We are proud members of the BCW and support their work whenever we can. We see the BCW as a great cheerleader in our community.”
Spreading the Open Hiring Gospel in 2023
While the bakery is for profit, its non-profit arm, the Greyston Foundation, teaches companies to do open hiring. “is year, we are doubling down on our training and development efforts,” notes Kenner. “We are building on
the success of partnering with IKEA as a global replication partner and will continue to spread the open hiring gospel. It’s gratifying to have our strategy recognized, increase the number of partners using this model, and seeing the huge impact it is having on the world.”
CORPORATE GIFTS THAT GIVE BACK
“We are ready, willing and able to be a corporate giing partner,” says Kenner. Visit https://shop.greyston.org/ pages/corporate-gis or call 914-234-8131 to learn more.
MITCHELL S. CAIRO, MD, GLOBAL LEADER IN LYMPHOMA RESEARCH AND TREATMENTS
Mitchell Cairo, MD, is Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation, Professor of Pediatrics, Medicine, Pathology, Microbiology
& Immunology and Cell Biology & Anatomy, Maria Fareri Children’s Hospital, Westchester Medical Center, New York Medical College.
Here, Dr. Cairo shares an overview of his groundbreaking work, and his Global
Symposium on Lymphomas, as well as the benefits of being based at Westchester Medical Center.
Our research program at the Westchester Medical Center (WMCHealth) and New York Medical College (NYMC) is focused on several areas including tumor immunology, cancer genetics and biology, stem, cellular and regenerative therapy, developmental therapeutics, and targeted therapy.
Some noteworthy recent research accomplishments include development of successful targeted antibody therapies for childhood, adolescent and
young adult Hodgkin Lymphoma and mature B-cell Lymphoma (100% survival) and the use of parental donors
“The environment at WMC Health is
ideal for translational research due to the support of hospital leadership, a skilled workforce and superb facilities, including a Good Manufacturing Practice processing facility (Cellular and Tissue Engineering Laboratory: CTEL)... terrific clinical facilities and clinical trials infrastructure, and exemplary nursing staff.” —Mitchell Cairo, MD
(haploidentical) to treat childhood, adolescent, and young adults with severe sickle cell disease with haploidentical stem cell transplantation (90% 1 year survival).
We just concluded the 7th International Symposium
on Childhood, Adolescent and Young Adult Lymphomas which was attended by 235 specialists from 28 countries and five continents. It was my
pleasure to serve as Chair, and
we welcomed over 175 scientific
presentations and state-of-the
art research in Lymphomas. is
Symposium was designed to
present the latest scientific and
clinical advances in childhood,
adolescent, and young adult
young adult non-Hodgkin
lymphoma, non-Hodgkin
lymphoma biopathology, non-
Hodgkin lymphoma genomics,
stem cell transplantation, immunobiology, imaging, late effects and survivorship, treatment, and prognosis.
On the horizon in 2023 will include our translational cellular therapy studies on patients with mild to moderate COVID-19 disease and other severe viral infections including cytomegalic, both congenital (neonatal) and in patients with immunocompromised diseases. We will additionally include studies with natural killer cells in Acute Leukemia and Chimeric Antigen Receptor (CAR) NK cells in patients with solid tumors.
e environment at WMCHealth is ideal for translational research due to the support of hospital leadership, a skilled workforce and superb facilities, including a Good Manufacturing Practice (GMP) processing facility (Cellular and Tissue Engineering Laboratory: CTEL - one of only
11 such labs), terrific clinical facilities and clinical trials infrastructure, and exemplary nursing staff
Above, le: Research illustrating the high efficacy of targeted antibody therapies for non-Hodgkin Lymphoma and mature B-cell Lymphoma. Above, right: Dr. Cairo served as Chair of
e 7th International Symposium on Childhood, Adolescent and Young Adult Lymphomas.
WESTCHESTER COUNTY ECONOMIC DEVELOPMENT GUIDE 11
© Courtesy of Dr. Mitchell Cairo © Courtesy of Dr. Mitchell Cairo
© Courtesy of Dr. Mitchell Cairo
